| # | Drug | Count |
|---|---|---|
| 0 | PACLITAXEL | 171 |
| 1 | PACLITAXEL (AIBUMIN-BOUND) | 154 |
| 2 | DOCETAXEL | 148 |
| 3 | DOCETAXEL ANHYDROUS | 148 |
| 4 | TRASTUZUMAB | 140 |
| 5 | CAPECITABINE | 119 |
| 6 | METHOTREXATE SODIUM | 97 |
| 7 | ADALIMUMAB | 90 |
| 8 | SECUKINUMAB | 87 |
| 9 | METHOTREXATE | 86 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FUTIBATINIB | 13 | 0.0586 |
| 1 | ERDAFITINIB | 58 | 0.0465 |
| 2 | PEMIGATINIB | 16 | 0.0188 |
| 3 | SENNOSIDES, STIMULANT LAXATIVE | 1 | 0.0139 |
| 4 | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | 2 | 0.0133 |
| 5 | RELACORILANT | 1 | 0.0101 |
| 6 | TALQUETAMAB-TGVS | 14 | 0.0094 |
| 7 | TELAVANCIN HYDROCHLORIDE | 1 | 0.0083 |
| 8 | COAL TAR | 6 | 0.0076 |
| 9 | TEA TREE OIL | 1 | 0.0053 |
| # | Drug class | Count |
|---|---|---|
| 0 | Microtubule Inhibitor [EPC] | 303 |
| 1 | Kinase Inhibitor [EPC] | 189 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 153 |
| 3 | Corticosteroid [EPC] | 150 |
| 4 | HER2/neu Receptor Antagonist [EPC] | 144 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 111 |
| 6 | Platinum-based Drug [EPC] | 108 |
| 7 | Interleukin-17A Antagonist [EPC] | 95 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 90 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 89 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 5 | 0.0073 |
| 1 | Interleukin-17A Antagonist [EPC] | 95 | 0.0025 |
| 2 | Sclerosing Agent [EPC] | 1 | 0.0022 |
| 3 | HER2/neu Receptor Antagonist [EPC] | 144 | 0.0019 |
| 4 | Microtubule Inhibitor [EPC] | 303 | 0.0018 |
| 5 | Provitamin D2 Compound [EPC] | 49 | 0.0016 |
| 6 | Cortisol Synthesis Inhibitor [EPC] | 1 | 0.0013 |
| 7 | Epidermal Growth Factor Receptor Antagonist [EPC] | 52 | 0.0011 |
| 8 | Opioid Antagonist [EPC] | 1 | 0.0010 |
| 9 | Plasma Volume Expander [EPC] | 3 | 0.0010 |